HEADER TRANSFERASE 26-OCT-22 8HAQ TITLE THE COMPLEX OF SRC WITH GW8510 COMPND MOL_ID: 1; COMPND 2 MOLECULE: ISOFORM 2 OF PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTO-ONCOGENE C-SRC,PP60C-SRC,P60-SRC; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SRC, SRC1; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS SRC-GW8510 COMPLEX, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.J.ZHU,S.Z.BI REVDAT 1 01-NOV-23 8HAQ 0 JRNL AUTH S.J.ZHU,S.Z.BI JRNL TITL THE COMPLEX OF SRC WITH GW8510 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.27 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.27 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.96 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.980 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 33316 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.207 REMARK 3 FREE R VALUE : 0.250 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.030 REMARK 3 FREE R VALUE TEST SET COUNT : 1677 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.9600 - 5.1900 0.96 2607 108 0.2024 0.2681 REMARK 3 2 5.1900 - 4.1200 0.97 2610 159 0.1814 0.1981 REMARK 3 3 4.1200 - 3.6000 0.98 2660 136 0.1900 0.2319 REMARK 3 4 3.6000 - 3.2700 0.98 2643 154 0.1962 0.2594 REMARK 3 5 3.2700 - 3.0400 0.98 2678 134 0.2191 0.2703 REMARK 3 6 3.0400 - 2.8600 0.98 2649 133 0.2099 0.2429 REMARK 3 7 2.8600 - 2.7200 0.98 2623 163 0.2147 0.2538 REMARK 3 8 2.7200 - 2.6000 0.98 2621 131 0.2337 0.2830 REMARK 3 9 2.6000 - 2.5000 0.97 2645 152 0.2346 0.2914 REMARK 3 10 2.5000 - 2.4100 0.97 2610 159 0.2489 0.2645 REMARK 3 11 2.4100 - 2.3400 0.97 2647 104 0.2553 0.3254 REMARK 3 12 2.3400 - 2.2700 0.97 2646 144 0.2747 0.3268 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.280 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.630 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.83 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.011 NULL REMARK 3 ANGLE : 1.288 NULL REMARK 3 CHIRALITY : 0.065 594 REMARK 3 PLANARITY : 0.022 705 REMARK 3 DIHEDRAL : 8.176 545 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8HAQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 06-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1300033185. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97914 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 33316 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.270 REMARK 200 RESOLUTION RANGE LOW (A) : 43.200 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.27 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.33 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 2BDF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.04 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.00 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MOPS PH 7.0, 18% PEG 3350, 5% REMARK 280 GLYCEROL, 5 MM TCEP, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 300 REMARK 465 THR A 301 REMARK 465 MET A 302 REMARK 465 SER A 303 REMARK 465 PRO A 304 REMARK 465 GLU A 305 REMARK 465 ALA A 306 REMARK 465 PHE A 307 REMARK 465 LEU A 308 REMARK 465 GLN A 309 REMARK 465 GLU A 310 REMARK 465 GLY A 406 REMARK 465 LEU A 407 REMARK 465 ALA A 408 REMARK 465 ARG A 409 REMARK 465 LEU A 410 REMARK 465 ILE A 411 REMARK 465 GLU A 412 REMARK 465 ASP A 413 REMARK 465 ASN A 414 REMARK 465 GLU A 415 REMARK 465 TYR A 416 REMARK 465 THR A 417 REMARK 465 ALA A 418 REMARK 465 ARG A 419 REMARK 465 GLN A 420 REMARK 465 GLY A 421 REMARK 465 ALA A 422 REMARK 465 LYS A 423 REMARK 465 PHE A 424 REMARK 465 LYS B 298 REMARK 465 PRO B 299 REMARK 465 GLY B 300 REMARK 465 THR B 301 REMARK 465 MET B 302 REMARK 465 SER B 303 REMARK 465 PRO B 304 REMARK 465 GLU B 305 REMARK 465 ALA B 306 REMARK 465 PHE B 307 REMARK 465 LEU B 308 REMARK 465 GLN B 309 REMARK 465 GLU B 310 REMARK 465 PHE B 405 REMARK 465 GLY B 406 REMARK 465 LEU B 407 REMARK 465 ALA B 408 REMARK 465 ARG B 409 REMARK 465 LEU B 410 REMARK 465 ILE B 411 REMARK 465 GLU B 412 REMARK 465 ASP B 413 REMARK 465 ASN B 414 REMARK 465 GLU B 415 REMARK 465 TYR B 416 REMARK 465 THR B 417 REMARK 465 ALA B 418 REMARK 465 ARG B 419 REMARK 465 GLN B 420 REMARK 465 GLY B 421 REMARK 465 ALA B 422 REMARK 465 LYS B 423 REMARK 465 PHE B 424 REMARK 465 LEU B 533 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 268 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 486 CG CD OE1 OE2 REMARK 470 GLN A 528 CG CD OE1 NE2 REMARK 470 GLN B 528 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 385 -13.72 84.94 REMARK 500 ASP A 386 57.36 -146.56 REMARK 500 GLU A 486 -1.24 74.14 REMARK 500 GLU B 486 -8.60 74.59 REMARK 500 REMARK 500 REMARK: NULL DBREF 8HAQ A 257 533 UNP P12931 SRC_HUMAN 266 542 DBREF 8HAQ B 257 533 UNP P12931 SRC_HUMAN 266 542 SEQRES 1 A 277 LYS ASP ALA TRP GLU ILE PRO ARG GLU SER LEU ARG LEU SEQRES 2 A 277 GLU VAL LYS LEU GLY GLN GLY CYS PHE GLY GLU VAL TRP SEQRES 3 A 277 MET GLY THR TRP ASN GLY THR THR ARG VAL ALA ILE LYS SEQRES 4 A 277 THR LEU LYS PRO GLY THR MET SER PRO GLU ALA PHE LEU SEQRES 5 A 277 GLN GLU ALA GLN VAL MET LYS LYS LEU ARG HIS GLU LYS SEQRES 6 A 277 LEU VAL GLN LEU TYR ALA VAL VAL SER GLU GLU PRO ILE SEQRES 7 A 277 TYR ILE VAL THR GLU TYR MET SER LYS GLY SER LEU LEU SEQRES 8 A 277 ASP PHE LEU LYS GLY GLU THR GLY LYS TYR LEU ARG LEU SEQRES 9 A 277 PRO GLN LEU VAL ASP MET ALA ALA GLN ILE ALA SER GLY SEQRES 10 A 277 MET ALA TYR VAL GLU ARG MET ASN TYR VAL HIS ARG ASP SEQRES 11 A 277 LEU ARG ALA ALA ASN ILE LEU VAL GLY GLU ASN LEU VAL SEQRES 12 A 277 CYS LYS VAL ALA ASP PHE GLY LEU ALA ARG LEU ILE GLU SEQRES 13 A 277 ASP ASN GLU TYR THR ALA ARG GLN GLY ALA LYS PHE PRO SEQRES 14 A 277 ILE LYS TRP THR ALA PRO GLU ALA ALA LEU TYR GLY ARG SEQRES 15 A 277 PHE THR ILE LYS SER ASP VAL TRP SER PHE GLY ILE LEU SEQRES 16 A 277 LEU THR GLU LEU THR THR LYS GLY ARG VAL PRO TYR PRO SEQRES 17 A 277 GLY MET VAL ASN ARG GLU VAL LEU ASP GLN VAL GLU ARG SEQRES 18 A 277 GLY TYR ARG MET PRO CYS PRO PRO GLU CYS PRO GLU SER SEQRES 19 A 277 LEU HIS ASP LEU MET CYS GLN CYS TRP ARG LYS GLU PRO SEQRES 20 A 277 GLU GLU ARG PRO THR PHE GLU TYR LEU GLN ALA PHE LEU SEQRES 21 A 277 GLU ASP TYR PHE THR SER THR GLU PRO GLN TYR GLN PRO SEQRES 22 A 277 GLY GLU ASN LEU SEQRES 1 B 277 LYS ASP ALA TRP GLU ILE PRO ARG GLU SER LEU ARG LEU SEQRES 2 B 277 GLU VAL LYS LEU GLY GLN GLY CYS PHE GLY GLU VAL TRP SEQRES 3 B 277 MET GLY THR TRP ASN GLY THR THR ARG VAL ALA ILE LYS SEQRES 4 B 277 THR LEU LYS PRO GLY THR MET SER PRO GLU ALA PHE LEU SEQRES 5 B 277 GLN GLU ALA GLN VAL MET LYS LYS LEU ARG HIS GLU LYS SEQRES 6 B 277 LEU VAL GLN LEU TYR ALA VAL VAL SER GLU GLU PRO ILE SEQRES 7 B 277 TYR ILE VAL THR GLU TYR MET SER LYS GLY SER LEU LEU SEQRES 8 B 277 ASP PHE LEU LYS GLY GLU THR GLY LYS TYR LEU ARG LEU SEQRES 9 B 277 PRO GLN LEU VAL ASP MET ALA ALA GLN ILE ALA SER GLY SEQRES 10 B 277 MET ALA TYR VAL GLU ARG MET ASN TYR VAL HIS ARG ASP SEQRES 11 B 277 LEU ARG ALA ALA ASN ILE LEU VAL GLY GLU ASN LEU VAL SEQRES 12 B 277 CYS LYS VAL ALA ASP PHE GLY LEU ALA ARG LEU ILE GLU SEQRES 13 B 277 ASP ASN GLU TYR THR ALA ARG GLN GLY ALA LYS PHE PRO SEQRES 14 B 277 ILE LYS TRP THR ALA PRO GLU ALA ALA LEU TYR GLY ARG SEQRES 15 B 277 PHE THR ILE LYS SER ASP VAL TRP SER PHE GLY ILE LEU SEQRES 16 B 277 LEU THR GLU LEU THR THR LYS GLY ARG VAL PRO TYR PRO SEQRES 17 B 277 GLY MET VAL ASN ARG GLU VAL LEU ASP GLN VAL GLU ARG SEQRES 18 B 277 GLY TYR ARG MET PRO CYS PRO PRO GLU CYS PRO GLU SER SEQRES 19 B 277 LEU HIS ASP LEU MET CYS GLN CYS TRP ARG LYS GLU PRO SEQRES 20 B 277 GLU GLU ARG PRO THR PHE GLU TYR LEU GLN ALA PHE LEU SEQRES 21 B 277 GLU ASP TYR PHE THR SER THR GLU PRO GLN TYR GLN PRO SEQRES 22 B 277 GLY GLU ASN LEU HET L1N A 601 46 HET L1N B 601 46 HETNAM L1N 4-[(~{E})-(7-OXIDANYL-6~{H}-PYRROLO[2,3-G][1, HETNAM 2 L1N 3]BENZOTHIAZOL-8-YL)METHYLIDENEAMINO]-~{N}-PYRIDIN-2- HETNAM 3 L1N YL-BENZENESULFONAMIDE FORMUL 3 L1N 2(C21 H15 N5 O3 S2) FORMUL 5 HOH *84(H2 O) HELIX 1 AA1 PRO A 263 GLU A 265 5 3 HELIX 2 AA2 SER A 345 LYS A 351 1 7 HELIX 3 AA3 THR A 354 LEU A 358 5 5 HELIX 4 AA4 ARG A 359 MET A 380 1 22 HELIX 5 AA5 ARG A 388 ALA A 390 5 3 HELIX 6 AA6 GLU A 396 LEU A 398 5 3 HELIX 7 AA7 PRO A 425 THR A 429 5 5 HELIX 8 AA8 ALA A 430 GLY A 437 1 8 HELIX 9 AA9 THR A 440 THR A 457 1 18 HELIX 10 AB1 VAL A 467 ARG A 477 1 11 HELIX 11 AB2 PRO A 488 TRP A 499 1 12 HELIX 12 AB3 GLU A 502 ARG A 506 5 5 HELIX 13 AB4 THR A 508 ASP A 518 1 11 HELIX 14 AB5 ASP A 518 THR A 523 1 6 HELIX 15 AB6 PRO B 263 GLU B 265 5 3 HELIX 16 AB7 ALA B 311 LYS B 316 5 6 HELIX 17 AB8 SER B 345 LYS B 351 1 7 HELIX 18 AB9 GLU B 353 LEU B 358 5 6 HELIX 19 AC1 ARG B 359 MET B 380 1 22 HELIX 20 AC2 ARG B 388 ALA B 390 5 3 HELIX 21 AC3 GLU B 396 LEU B 398 5 3 HELIX 22 AC4 PRO B 425 THR B 429 5 5 HELIX 23 AC5 ALA B 430 GLY B 437 1 8 HELIX 24 AC6 THR B 440 THR B 457 1 18 HELIX 25 AC7 VAL B 467 ARG B 477 1 11 HELIX 26 AC8 PRO B 488 TRP B 499 1 12 HELIX 27 AC9 GLU B 502 ARG B 506 5 5 HELIX 28 AD1 THR B 508 ASP B 518 1 11 HELIX 29 AD2 ASP B 518 THR B 523 1 6 SHEET 1 AA1 5 LEU A 267 GLY A 276 0 SHEET 2 AA1 5 GLY A 279 TRP A 286 -1 O MET A 283 N VAL A 271 SHEET 3 AA1 5 THR A 290 LEU A 297 -1 O ILE A 294 N TRP A 282 SHEET 4 AA1 5 ILE A 334 GLU A 339 -1 O THR A 338 N ALA A 293 SHEET 5 AA1 5 LEU A 325 VAL A 329 -1 N TYR A 326 O VAL A 337 SHEET 1 AA2 2 ILE A 392 VAL A 394 0 SHEET 2 AA2 2 CYS A 400 VAL A 402 -1 O LYS A 401 N LEU A 393 SHEET 1 AA3 5 LEU B 267 GLN B 275 0 SHEET 2 AA3 5 GLU B 280 TRP B 286 -1 O VAL B 281 N LEU B 273 SHEET 3 AA3 5 THR B 290 THR B 296 -1 O THR B 296 N GLU B 280 SHEET 4 AA3 5 TYR B 335 THR B 338 -1 O ILE B 336 N LYS B 295 SHEET 5 AA3 5 LEU B 325 VAL B 329 -1 N TYR B 326 O VAL B 337 SHEET 1 AA4 2 ILE B 392 VAL B 394 0 SHEET 2 AA4 2 CYS B 400 VAL B 402 -1 O LYS B 401 N LEU B 393 CISPEP 1 GLU A 332 PRO A 333 0 17.30 CISPEP 2 GLU B 332 PRO B 333 0 -0.12 CRYST1 41.830 62.580 74.260 79.30 87.98 89.73 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.023906 -0.000113 -0.000837 0.00000 SCALE2 0.000000 0.015980 -0.003019 0.00000 SCALE3 0.000000 0.000000 0.013713 0.00000